To summarize, the TMA results suggest that PLIN2 may serve as a sensitive and specific marker for ccRCC, beta-tubulin III for pRCC, HK1 for RO, and diffuse LAMP1 for chRCC. This evidence concerns the gene HK1 and chromophobe renal cell carcinoma.